Dara Wright - 16 Dec 2022 Form 4 Insider Report for BIO-RAD LABORATORIES, INC. (BIO)

Role: Executive Vice President
Signature: /s/ Dara Wright
Issuer symbol: BIO
Transactions as of: 16 Dec 2022
Net transactions value: -$92,203
Form type: 4
Filing time: 19 Dec 2022, 10:52:44 UTC
Previous filing: 07 Sep 2022
Next filing: 06 Sep 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BIO	Bio-Rad A Common Stock	Options Exercise	$0	+502	+34%	$0.000000	1,988	16 Dec 2022	Direct	F1, F2
transaction	BIO	Bio-Rad A Common Stock	Tax liability	$92,203	-226	-11%	$407.98	1,762	16 Dec 2022	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BIO	Restricted Stock Units	Options Exercise	$0	-502	-33%	$0.000000	1,005	16 Dec 2022	Bio-Rad A Common Stock	502	$0.000000	Direct	F3, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares of Class A common stock acquired on the vesting of restricted stock units.
F2	Includes 26.0150 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 09/30/2022.
F3	Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
F4	On December 16, 2019, the reporting person was granted 2,511 restricted stock units, vesting in 5 equal annual installments beginning on the first anniversary of the grant date.